Remepy
Ramat Gan
About Remepy
Remepy is biotechnology research pioneering hybrid drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™. It was founded in 2022 and is located in Ramat Gan, Tel Aviv.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $15.0M
- Funding stage: Seed
- Last round: Seed (May 2024)
- Website: remepy.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/remepy-78822 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.